-
The challenges of dengue drug discovery and development
Feng Gu, Pei-Yong Shi
Editorial: Clinical Investigation
-
The challenges of dengue drug discovery and development
Feng Gu, Pei-Yong Shi
Editorial: Clinical Investigation
-
The challenges of dengue drug discovery and development
Feng Gu, Pei-Yong Shi
Editorial: Clinical Investigation
-
The challenges of dengue drug discovery and development
Feng Gu, Pei-Yong Shi
Editorial: Clinical Investigation
-
The challenges of dengue drug discovery and development
Feng Gu, Pei-Yong Shi
Editorial: Clinical Investigation
-
The challenges of dengue drug discovery and development
Feng Gu, Pei-Yong Shi
Editorial: Clinical Investigation
-
The benefits of including expansion cohorts in Phase I oncology clinical trial design
Aaron R Hansen, Albiruni RA Razak
Editorial: Clinical Investigation
-
The benefits of including expansion cohorts in Phase I oncology clinical trial design
Aaron R Hansen, Albiruni RA Razak
Editorial: Clinical Investigation
-
The benefits of including expansion cohorts in Phase I oncology clinical trial design
Aaron R Hansen, Albiruni RA Razak
Editorial: Clinical Investigation
-
The benefits of including expansion cohorts in Phase I oncology clinical trial design
Aaron R Hansen, Albiruni RA Razak
Editorial: Clinical Investigation
-
The benefits of including expansion cohorts in Phase I oncology clinical trial design
Aaron R Hansen, Albiruni RA Razak
Editorial: Clinical Investigation
-
The benefits of including expansion cohorts in Phase I oncology clinical trial design
Aaron R Hansen, Albiruni RA Razak
Editorial: Clinical Investigation
-
Implications of BRCA1 and BRCA2 status for cancer clinical study outcomes
Alan Christie, David Cameron & Charlie Gourley
Review: Clinical Trail Outcomes: Clinical Investigation
-
Implications of BRCA1 and BRCA2 status for cancer clinical study outcomes
Alan Christie, David Cameron & Charlie Gourley
Review: Clinical Trail Outcomes: Clinical Investigation
-
Implications of BRCA1 and BRCA2 status for cancer clinical study outcomes
Alan Christie, David Cameron & Charlie Gourley
Review: Clinical Trail Outcomes: Clinical Investigation
-
Implications of BRCA1 and BRCA2 status for cancer clinical study outcomes
Alan Christie, David Cameron & Charlie Gourley
Review: Clinical Trail Outcomes: Clinical Investigation
-
Implications of BRCA1 and BRCA2 status for cancer clinical study outcomes
Alan Christie, David Cameron & Charlie Gourley
Review: Clinical Trail Outcomes: Clinical Investigation
-
Implications of BRCA1 and BRCA2 status for cancer clinical study outcomes
Alan Christie, David Cameron & Charlie Gourley
Review: Clinical Trail Outcomes: Clinical Investigation
-
Dalbavancin: re-enforcing the arsenal against Gram-positive bacteria causing skin and skin structure infections
Konstantinos Z Vardakas & Matthew E Falagas
Review: Clinical Trail Outcomes: Clinical Investigation
-
Dalbavancin: re-enforcing the arsenal against Gram-positive bacteria causing skin and skin structure infections
Konstantinos Z Vardakas & Matthew E Falagas
Review: Clinical Trail Outcomes: Clinical Investigation
-
Dalbavancin: re-enforcing the arsenal against Gram-positive bacteria causing skin and skin structure infections
Konstantinos Z Vardakas & Matthew E Falagas
Review: Clinical Trail Outcomes: Clinical Investigation
-
Dalbavancin: re-enforcing the arsenal against Gram-positive bacteria causing skin and skin structure infections
Konstantinos Z Vardakas & Matthew E Falagas
Review: Clinical Trail Outcomes: Clinical Investigation
-
Dalbavancin: re-enforcing the arsenal against Gram-positive bacteria causing skin and skin structure infections
Konstantinos Z Vardakas & Matthew E Falagas
Review: Clinical Trail Outcomes: Clinical Investigation
-
Dalbavancin: re-enforcing the arsenal against Gram-positive bacteria causing skin and skin structure infections
Konstantinos Z Vardakas & Matthew E Falagas
Review: Clinical Trail Outcomes: Clinical Investigation
-
Potential utility of biomarkers in the diagnosis and treatment of ALS
Benjamin Chee Chuan Cheah, Steve Vucic, Matthew Colm Kiernan
Review: Clinical Trail Outcomes: Clinical Investigation
-
Potential utility of biomarkers in the diagnosis and treatment of ALS
Benjamin Chee Chuan Cheah, Steve Vucic, Matthew Colm Kiernan
Review: Clinical Trail Outcomes: Clinical Investigation
-
Potential utility of biomarkers in the diagnosis and treatment of ALS
Benjamin Chee Chuan Cheah, Steve Vucic, Matthew Colm Kiernan
Review: Clinical Trail Outcomes: Clinical Investigation
-
Potential utility of biomarkers in the diagnosis and treatment of ALS
Benjamin Chee Chuan Cheah, Steve Vucic, Matthew Colm Kiernan
Review: Clinical Trail Outcomes: Clinical Investigation
-
Potential utility of biomarkers in the diagnosis and treatment of ALS
Benjamin Chee Chuan Cheah, Steve Vucic, Matthew Colm Kiernan
Review: Clinical Trail Outcomes: Clinical Investigation
-
Potential utility of biomarkers in the diagnosis and treatment of ALS
Benjamin Chee Chuan Cheah, Steve Vucic, Matthew Colm Kiernan
Review: Clinical Trail Outcomes: Clinical Investigation